Cryo Cell International (CCEL) Non Operating Investment Income (2019 - 2026)
Cryo Cell International (CCEL) posted quarterly Non Operating Investment Income of $72019.0 for Q2 2026, up 118.99% year-over-year from $32887.5 in Q2 2025, and up 129.95% quarter-over-quarter from -$240458.0 in Q1 2026.
Cryo Cell International (CCEL) Non Operating Investment Income (2019 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported Non Operating Investment Income for 8 consecutive years, with $72019.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Non Operating Investment Income rose 118.99% year-over-year to $72019.0; the TTM figure through May 2026 stood at -$563973.0 (down 528.15% YoY), while the FY2025 annual figure was -$806267.0, down 174.93% from the prior year.
- Non Operating Investment Income rose to $72019.0 in Q2 2026 per CCEL's latest filing, from -$240458.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $522458.0 in Q3 2024 and bottomed at -$379332.0 in Q2 2025.
- Historically, Non Operating Investment Income has averaged $6286.1 across 5 years, with a median of -$6161.5 in 2022.
- Annual changes were most pronounced in 2023 — Non Operating Investment Income plunged 9473.79% — and 2024, when it jumped 7570.01%.
- Cryo Cell International's Non Operating Investment Income stood at -$515.0 in 2022, then slumped by 9473.79% to -$49305.0 in 2023, then jumped by 140.56% to $19999.0 in 2024, then tumbled by 1108.29% to -$201648.0 in 2025, then surged by 135.72% to $72019.0 in 2026.
- Business Quant data shows CCEL's Non Operating Investment Income at $72019.0 in Q2 2026, -$240458.0 in Q1 2026, and -$201648.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | - |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | - |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn | 72,019.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 72,019.00 |
| May 31, 2026 | 72,019.00 |
| Feb 28, 2026 | -240,458.00 |
| Feb 28, 2026 | -240,458.00 |
| Nov 30, 2025 | -201,648.00 |
| Nov 30, 2025 | -201,648.00 |
| Aug 31, 2025 | -193,886.00 |
| Aug 31, 2025 | -193,886.00 |
| May 31, 2025 | -379,332.00 |
| May 31, 2025 | -379,332.00 |
| Feb 28, 2025 | -31,401.00 |
| Feb 28, 2025 | -31,401.00 |
| Nov 30, 2024 | 19,999.00 |
| Nov 30, 2024 | 19,999.00 |
| Aug 31, 2024 | 522,458.00 |
| Aug 31, 2024 | 522,458.00 |
| May 31, 2024 | 258,623.00 |
| May 31, 2024 | 258,623.00 |
| Feb 29, 2024 | 274,971.00 |
| Feb 29, 2024 | 274,971.00 |